NCT03224091

Brief Summary

The PROLED study is a prospective and longitudinal study of patients with Eating Disorders. Annual interviews and collection of biological samples are done, as well as during changes in disease course e.g. during hospitalization. Included are qualitative interviews, psychometric tests, questionnaires which are used to collect data on psychopathology. There is also collection of blood, urine and faeces.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
48mo left

Started Jan 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress73%
Jan 2016Apr 2030

Study Start

First participant enrolled

January 25, 2016

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

March 23, 2017

Completed
4 months until next milestone

First Posted

Study publicly available on registry

July 21, 2017

Completed
12.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2030

Last Updated

April 7, 2022

Status Verified

April 1, 2022

Enrollment Period

14.2 years

First QC Date

March 23, 2017

Last Update Submit

April 6, 2022

Conditions

Keywords

Eating disorderspsychopathologypathophysiologyprospectivelongitudinal

Outcome Measures

Primary Outcomes (2)

  • GAF-F total score

    Change in Global level of functioning will be assessed using the GAF-F score for the whole population of treated individuals

    through study completion, an average of 1 year

  • BMI change over time

    Change in Body Mass Index (BMI) will be assess in the whole population of Anorexia Nervosa patients and compared to other diagnoses and Healthy controls, change over time

    through study completion, an average of 1 year

Secondary Outcomes (5)

  • MDI

    through study completion, an average of 1 year

  • cytokines in plasma

    through study completion, an average of 1 year

  • Biomarkers in blood

    through study completion, an average of 1 year

  • Total score on CogTrac

    through study completion, an average of 1 year

  • Change in EDI

    through study completion, an average of 1 year

Study Arms (3)

Patients at Psychiatric Center Ballerup

Healthy Controls

Healthy Controls recovered from an eating disorder

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients at Psychiatric Center Ballerup with Eating Disorders

You may qualify if:

  • Eating Disorder (ICD-10)

You may not qualify if:

  • Forced care/non-voluntary

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mental Health Center

Ballerup Municipality, Capitol Region, 2750, Denmark

RECRUITING

MeSH Terms

Conditions

Anorexia NervosaBulimia NervosaBinge-Eating DisorderFeeding and Eating Disorders

Condition Hierarchy (Ancestors)

Mental DisordersSigns and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Louise Behrend_Rasmussen, MD,PhD

    Mental Health Center Ballerup

    STUDY CHAIR

Central Study Contacts

Magnus JC Sjögren, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Associate Professor, Sr Consultant Psychiatrist

Study Record Dates

First Submitted

March 23, 2017

First Posted

July 21, 2017

Study Start

January 25, 2016

Primary Completion (Estimated)

April 1, 2030

Study Completion (Estimated)

April 1, 2030

Last Updated

April 7, 2022

Record last verified: 2022-04

Locations